Sucampo Pharma Inc (SCMP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2017 | 06-2017 | 03-2017 | 12-2016 | 09-2016 | |
| Sales | 61,266 | 59,896 | 56,283 | 73,024 | 57,873 |
| Cost of Goods | 17,436 | 17,035 | 16,883 | 16,725 | 15,586 |
| Gross Profit | 43,830 | 42,861 | 39,400 | 56,299 | 42,287 |
| Operating Expenses | 23,066 | 218,731 | 29,423 | 23,531 | 29,605 |
| Operating Income | 21,200 | -175,835 | 10,860 | 33,493 | 13,268 |
| Interest Expense | 2,956 | 2,916 | 2,890 | 5,620 | 5,899 |
| Other Income | -673 | -476 | 239 | -21,022 | 8,133 |
| Pre-tax Income | 17,571 | -179,227 | 8,209 | 6,851 | 15,502 |
| Income Tax | 7,204 | 1,940 | 3,585 | -8,433 | 7,410 |
| Net Income Continuous | 10,367 | -181,167 | 4,624 | 15,284 | 8,092 |
| Net Income | $10,367 | $-181,167 | $4,624 | $15,284 | $8,092 |
| EPS Basic Total Ops | 0.22 | -3.92 | 0.11 | 0.36 | 0.19 |
| EPS Basic Continuous Ops | 0.22 | -3.92 | 0.11 | 0.36 | 0.19 |
| EPS Diluted Total Ops | 0.19 | -3.92 | 0.10 | 0.35 | 0.19 |
| EPS Diluted Continuous Ops | 0.16 | -3.92 | 0.07 | 0.35 | 0.19 |
| EPS Diluted Before Non-Recurring Items | 0.27 | 0.28 | 0.23 | 0.68 | 0.28 |
| EBITDA(a) | $28,674 | $-168,377 | $18,282 | $41,303 | $21,043 |